Paid Clinical Trials Ogden
Discover 712 paid clinical trials in Ogden, Utah. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Odronextamab & RituximabA Trial to Learn if Odronextamab Combined With Chemotherapy is Safe and Well-Tolerated and How Well it Works Compared to Rituximab Combined With Chemotherapy for Adult Participants With Follicular Lymphoma
Sponsor:
Regeneron Pharmaceuticals
Location:
Code:
NCT06097364
Conditions
Follicular Lymphoma (FL)
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Odronextamab
Rituximab
Cyclophosphamide
Doxorubicin
Vincristine
IanalumabStudy of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP)
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT05653349
Conditions
Primary Immune Thrombocytopenia (ITP)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ianalumab
Placebo
Corticosteroids
Amlitelimab with CorticosteroidsA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor
Sponsor:
Sanofi
Location:
Code:
NCT06241118
Conditions
Dermatitis Atopic
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Amlitelimab
Placebo
Topical corticosteroids
Topical tacrolimus or pimecrolimus
CryoablationCryoablation of Small Breast Tumors in Early Stage Breast Cancer
Sponsor:
Sanarus Technologies, Inc.
Location:
Code:
NCT01992250
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 50+
Healthy Volunteers: Not accepted
Interventions
Visica 2 Treatment System
AmlitelimabA Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
Sponsor:
Sanofi
Location:
Code:
NCT06181435
Conditions
Dermatitis Atopic
Eligibility Criteria
Sex: All
Age: 12+
Healthy Volunteers: Not accepted
Interventions
Amlitelimab
Placebo
TEACHTelehealth-Enabled, Real-time Audit and Feedback for Clinician AdHerence (TEACH)
Sponsor:
Intermountain Health Care, Inc.
Location:
Code:
NCT05141396
Conditions
Respiration, Artificial
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Telehealth- enabled support for SAT/SBT adherence
Usual audit and feedback for SAT/SBT adherence
TAK-101Dose-Ranging Study of the Efficacy and Safety of TAK-101 for Prevention of Gluten-Specific T Cell Activation in Participants With Celiac Disease on a Gluten-Free Diet
Sponsor:
Takeda
Location:
Code:
NCT04530123
Conditions
Celiac Disease
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Placebo
TAK-101
Gluten
Epcoritamab & LenalidomideA Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Genmab
Location:
Code:
NCT06508658
Conditions
Diffuse Large B-Cell Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Epcoritamab
Rituximab
Lenalidomide
Oxaliplatin
Gemcitabine
ProLung TestEstablish ProLung Test Measurement Collection Protocol for Future Studies.
Sponsor:
Fresh Medical Laboratories
Location:
Code:
NCT04134520
Conditions
Cancer , Healthy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ProLung System
Observational StudyContinuous Monitoring and Control of Hypoglycemia
Sponsor:
DexCom, Inc.
Location:
Code:
NCT03340831
Conditions
Diabetes
Eligibility Criteria
Sex: All
Age: 2+
Healthy Volunteers: Not accepted
Interventions
Continuous Glucose Monitoring (CGM)